Mahmoud Mahafzah, MD
Pulmonary Disease · Phoenix, AZNPI 1649434887
Payments from drug & device makers
Across 51 payments — averaging $158.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Steris Corporation$3K
- Philips North America LLC$235
- Takeda Pharmaceuticals U.S.A., Inc.$116
- Mentor Worldwide LLC$97
- Johnson & Johnson$84
- plus $507 from 15 others
What the payments were for
- Travel & lodging$3,48743%
- Food & beverage$1,61220%
- Education$3,00037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $4,259 |
| Steris Corporation | 4 | $2,801 |
| Philips North America LLC | 4 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $116 |
| Mentor Worldwide LLC | 1 | $97 |
| Johnson & Johnson | 4 | $84 |
| Genentech USA, Inc. | 3 | $69 |
| GSK | 4 | $62 |
| AstraZeneca | 4 | $60 |
| Boehringer Ingelheim | 2 | $49 |
| Galvanize Therapeutics, Inc | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Vapotherm Inc | 1 | $26 |
| Bayer | 1 | $24 |
| AbbVie | 1 | $24 |
| Abbott | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- TRUFREEZE$2,633
- Da Vinci Surgical System$726
- GLASSIA$116
How this compares
$8,099 in reported general payments places this provider in the 65th percentile of 250 pulmonary disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Phoenix
- David BaratzPhoenix$2.2M
- James RossPhoenix$2M
- Rajat WaliaPhoenix$1.9M
- Mark GotfriedPhoenix$1.1M
- Abid KhokarPhoenix$321K
- Brian PorvinPhoenix$276K
- Tony HodgesPhoenix$262K
- Rajeev SaggarPhoenix$219K
- Ali SaeedPhoenix$213K
- Bhuvin BuddhdevPhoenix$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.